We showed that CBX8 interacted with RYBP and BMI1 in GBM lines as well as in patient-derived GIC, as assessed by increased GFP intensity following the proximity of complementing GFP- tagged antibodies targeting CBX8 and RYBP (Supplementary Figure S3C,D). Here, BMI1 is linked to glioblastoma.